NCT03874897 2024-04-30Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.Peking UniversityPhase 1 Completed134 enrolled
NCT04357756 2023-09-13A Study to Assess YH001 in Combination With Toripalimab Injection in Subjects With Advanced Solid TumorsEucure (Beijing) Biopharma Co., LtdPhase 1 Completed29 enrolled